Overall US clinical burden of Alcoholic liver disease (ALD) remains unclear, perhaps because of lack of a definitive standard for identifying ALD. This study focused on the specific, more well-defined subset of alcoholic fatty liver disease (AFLD) to estimate national prevalence among US adults.

Author

Terrence Wong, Katherine Dang, Sanah Ladhani, Ashwani K. Singal, Robert J. Wong

Citation

Wong T, Dang K, Ladhani S, Singal AK, Wong RJ. Prevalence of Alcoholic Fatty Liver Disease Among Adults in the United States, 2001-2016. JAMA. 2019;321(17):1723–1725. doi:10.1001/jama.2019.2276

Source
JAMA
Release date
07/05/2019

Prevalence of Alcoholic Fatty Liver Disease Among Adults in the United States, 2001-2016

Research Article

Abstract

Alcoholic liver disease (ALD), comprising a spectrum of diseases ranging from alcoholic fatty liver disease (AFLD) to advanced ALD (including alcoholic hepatitis, cirrhosis, and cirrhosis complications), is a leading cause of mortality in the United States, with nearly 250 000 deaths attributed to ALD in 2010. Overall US clinical burden of ALD remains unclear, perhaps because of lack of a definitive standard for identifying ALD. This study focused on the specific, more well-defined subset of AFLD to estimate national prevalence among US adults.

Source Website: JAMA Network